Approach to Antimicrobial Prophylaxis for Urology Procedures in the Era of Increasing Fluoroquinolone Resistance

Annals of Pharmacotherapy

Volumn 48, Issue 3, 2014, Pages 380-386

  Marino Sabo, Elizabeth ^a   Stern, John J ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

antibiotic; drug resistance; fluoroquinolones; prophylaxis; urologic surgical procedures

Indexed keywords

ANTIINFECTIVE AGENT; CEFAZOLIN; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL PROPHYLAXIS; ESCHERICHIA COLI; HUMAN; INFECTIOUS COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SURGICAL INFECTION; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URETHROTOMY; URINARY CATHETER; URINE CULTURE; UROLOGIC SURGERY;

ANTIBIOTIC; DRUG RESISTANCE; FLUOROQUINOLONES; PROPHYLAXIS; UROLOGIC SURGICAL PROCEDURES;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; UROLOGIC SURGICAL PROCEDURES;

EID: 84896856491     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013517661     Document Type: Review

References (25)

1. Zaytoun OM,Vargo EH,Rajan R,Berglund R,Gordon S,Jones JS.Emergence of fluoroquinolone resistant Escherichia coli as a cause of postprostate biopsy infection: implications for prophylaxis and treatment.Urology. 2011;77:1035-1041.
2. Feliciano J,Teper E,Ferrandino M,et al.The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis?.J Urol. 2008;179:952-955.
3. Binsaleh S,Al-Assiri M,Aronson S,Steinberg A.Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting?.Can J Urol. 2004;11:2352-2353.
4. Taur Y,Smith MA.Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection.Clin Infect Dis. 2007;44:769-774.
5. Grover ML,Bracamonte JD,Kanodia AK,et al.Assessing adherence to evidence-based guidelines for the diagnosis and management of uncomplicated urinary tract infection.Mayo Clin Proc. 2007;82:181-185.
6. Andriole VT.The quinolones: past, present, and future.Clin Infect Dis. 2005;41:S113-S119.
7. Pearle MS.Should we change our prophylactic antimicrobial regimen for prostate biopsy?.J Urol. 2011;185:1181-1183.
8. Lange D,Zappavigna C,Hamidizadeh R,Goldenberg SL,Paterson RF,Chew BH.Bacterial sepsis after prostate biopsy-a new perspective.Urology. 2009;74:1200-1205.
9. Jung SI,Park JB,Hwang EC,et al.Clinical aspect of post transrectal ultrasound guided prostate biopsy infection caused by quinolone-resistant bacteria.J Urol. 2010;183:e315-e316.
10. Taylor AK,Zembower TR,Nadler RB,et al.Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.J Urol. 2012;187:1275-1279.
11. Liss MA,Chang A,Santos R,et al.Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.J Urol. 2011;185:1283-1288.
12. Liss MA,Peeples AN,Peterson EM.Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy.J Clin Microbiol. 2011;49:1116-1118.
13. Steensels D,Slabbaert K,De Wever L,Vermeersch P,Van Poppel H,Verhaegen J.Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis?.Clin Microbiol Infect. 2012;18:575-581.
14. Duplessis CA,Bavaro M,Simons MP,et al.Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.Urology. 2012;79:556-561.
15. Minamida S,Satoh T,Tabata K,et al.Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.Urology. 2011;78:1235-1239.
16. Cox CE.Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery.Am J Med. 1989;87:252S-254S.
17. Gombert ME,duBouchet L,Aulicino TM,Berkowitz LB,Macchia RJ.Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery.Am J Med. 1989;87:250S-251S.
18. Lukkarinen O,Hellström P,Leppilahti M,Kontturi M,Tammela T.Antimicrobial prophylaxis in patients with urinary retention undergoing transurethral prostatectomy.Ann Chir Gynaecol. 1997;86:239-242.
19. Christiano AP,Hollowell CM,Kim H,et al.Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.Urology. 2000;55:182-185.
20. Naber KG,Bergman B,Bishop MC,et al.EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infections (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).Eur Urol. 2001;40:576-588.
21. Botto H,Naber KG,Bishop MC,Jarlier V,Lim V,Norby RNosocomial and Health Care Associated Infections in Urology. Naber KGPechere JCKumazawa J, ed. Plymouth, England: Health Publications; 2001:177-221.
22. Zhanel GG,Hisanaga TL,Laing NM,et al.Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).Int J Antimicrob Agents. 2006;27:468-475.
23. Owens RC,Donskey CJ,Gaynes RP,Loo VG,Muto CA.Antimicrobial-associated risk factors for Clostridium difficile infection.Clin Infect Dis. 2008;46:S19-S31.
24. Lautenbach E,Metlay JP,Bilker WB,Edelstein PH,Fishman NO.Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.Clin Infect Dis. 2005;41:923-929.
25. Gupta K,Hooton TM,Naber KG,et al.International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.Clin Infect Dis. 2011;52:e103-e120.